top of page

Our Team

IMMvention is powered by its experienced team with deep expertise in drug discovery and development across multiple therapeutic areas

Don Haut
Don Haut, PhD
Executive Chair
McKinsey & Company
MDCO Company
Aspect
AskBio
Anil Goyal
Anil Goyal, PhD
CEO and Co-founder
Ribo
Millennium Takeda
Serenex
matthew gallovic
Matt Gallovic, PhD
Sr. Director of R&D
Baxter
UNC Chapel Hill
IMG_6287(1)_edited_edited.jpg
Montana Wagner-Gillespie
Program Director
Tiamet.jpeg
biomilq.png
Wakemed logo.png
Roheeth Pavana.jpeg
Roheeth Pavana, PhD
Director, Medicinal Chemistry
Ribo
Raybow.png
newlink_edited.jpg
gsk.jpeg
IMMvention-Background.png

Board of Directors

EXECUTIVE CHAIR
Don Haut, PhD, Independent
CEO and DIRECTOR
Anil Goyal, PhD, IMMvention
DIRECTOR and CO-FOUNDER
Jenny Ting, PhD, UNC, Chapel Hill
DIRECTOR
Matt Cohen, PhD, Osage University Partners
DIRECTOR
Ben Scruggs, PhD, Hatteras Venture Partners
DIRECTOR
Matt Keeling, Delin Ventures
OBSERVER
Caroline Haegeman, PhD, Delin Ventures
Justin Robeny, PhD, Osage University Partners
OBSERVER
orangeGlow.jpg

Let's collaborate

Interested in partnering with us? Reach out to start the conversation
Immvention mark

© 2026 IMMvention Therapeutix

bottom of page